Core expertise
Drug discovery
Biography
Chris has a strong interest in drug discovery, having spent 15 years working in the pharmaceutical and biotech industry in the UK, where he led project teams to discover four pre-clinical candidate drugs. and managed collaborations with academic labs and other pharmaceutical companies.
He has a particular interest in GPCRs as drug targets in neurodegenerative and psychiatric disorders and recently co-established Phrenix Therapeutics to advance highly targeted therapeutics for neurological conditions.
